Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1601
DELISTED
Immunogen Inc
IMGN
| $7.01M | 0.01% |
1,093,240
+568,900
| +108% | +$3.51M |
|
|
PBIP
1602
DELISTED
Prudential Bancorp, Inc.
PBIP
| $6.98M | 0.01% |
396,790
+22,000
| +6% | +$401K |
|
|
STFC
1603
DELISTED
State Auto Financial Corp
STFC
| $6.98M | 0.01% |
239,700
+13,100
| +6% | +$354K |
|
1604
Camtek
CAMT
$8.06B
| $6.94M | 0.01% |
1,213,960
+90,260
| +8% | +$523K |
|
1605
MiMedx Group
MDXG
$612M
| $6.94M | 0.01% |
550,500
+23,400
| +4% | +$285K |
|
1606
Federal Signal
FSS
$7.51B
| $6.94M | 0.01% |
345,300
+229,000
| +197% | +$4.8M |
|
1607
Everest Group
EG
$14B
| $6.92M | 0.01% |
31,300
-109,600
| -78% | -$24.7M |
|
|
VRNT
1608
DELISTED
Verint Systems
VRNT
| $6.91M | 0.01% |
324,032
-292,487
| -47% | -$6.29M |
|
|
AKAO
1609
DELISTED
Achaogen Inc
AKAO
| $6.9M | 0.01% |
642,700
+623,900
| +3,319% | +$7.83M |
|
1610
EnerSys
ENS
$7.2B
| $6.87M | 0.01% |
98,685
-37,815
| -28% | -$2.59M |
|
|
KIN
1611
DELISTED
Kindred Biosciences, Inc.
KIN
| $6.87M | 0.01% |
727,063
-99,737
| -12% | -$779K |
|
|
ESSA
1612
DELISTED
ESSA Bancorp
ESSA
| $6.85M | 0.01% |
437,300
+1,622
| +0.4% | +$25.6K |
|
|
REGI
1613
DELISTED
Renewable Energy Group, Inc.
REGI
| $6.85M | 0.01% |
580,219
+57,614
| +11% | +$666K |
|
|
GOOS
1614
Canada Goose Holdings
GOOS
$850M
| $6.8M | 0.01% |
+215,400
| New | +$5.29M |
|
1615
Stewart Information Services
STC
$2.07B
| $6.8M | 0.01% |
160,700
-79,500
| -33% | -$3.14M |
|
1616
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $6.79M | 0.01% |
+77,800
| New | +$6.83M |
|
1617
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $6.79M | 0.01% |
89,700
-60,800
| -40% | -$4.42M |
|
1618
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $6.77M | 0.01% |
+245,800
| New | +$6.81M |
|
1619
Tetra Tech
TTEK
$9.33B
| $6.77M | 0.01% |
703,000
-119,500
| -15% | -$1.16M |
|
1620
Ligand Pharmaceuticals
LGND
$5.76B
| $6.76M | 0.01% |
+79,188
| New | +$6.86M |
|
1621
Snap-on
SNA
$20.9B
| $6.76M | 0.01% |
38,800
-455,100
| -92% | -$73.6M |
|
|
CAI
1622
DELISTED
CAI International, Inc.
CAI
| $6.76M | 0.01% |
238,795
+47,495
| +25% | +$1.57M |
|
1623
inTEST
INTT
$174M
| $6.75M | 0.01% |
780,500
+52,100
| +7% | +$462K |
|
1624
POSCO
PKX
$17.1B
| $6.74M | 0.01% |
86,200
+1,800
| +2% | +$133K |
|
|
NTUS
1625
DELISTED
Natus Medical Inc
NTUS
| $6.73M | 0.01% |
+176,245
| New | +$7.04M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.